This article is more than 5 years old. Information may no longer be current.

Cooper completes acquisition of Ocular Sciences

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LAKE FOREST, Calif. -- The Cooper Companies Inc., parent company of CooperVision, has announced the completion of its acquisition of Ocular Sciences Inc.

At closing, Cooper paid approximately $600 million in cash and issued roughly 10.7 million shares of its common stock to Ocular Sciences stockholders and option holders.

“We firmly believe that the integration of these businesses will help CooperVision better fulfill our promise to provide eye care practitioners with the highest levels of service, as well as product quality, reliability and delivery,” said Greg Fryling, COO of CooperVision, in a press release.

The company has launched a new Web site, www.CooperVisionOSI.com, dedicated to disseminating information about the merger to eye care professionals. The new site also features a special response tool that allows practitioners to submit questions or comments regarding the transition. The existing CooperVision and Ocular Sciences Web sites will also remain operational, the press release stated.